VIJAYA1,503.00

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹15,465 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations547.8681.4814.2857.1
Other Income20.818.320.822.3
Total Income568.6699.7835.0879.4
Expenses
+ Cost of Materials Consumed65.484.894.798.9
+ Employee Benefit Expense90.2112.2130.7136.6
+ Finance Costs24.026.733.236.7
+ Depreciation & Amortisation57.070.691.896.1
+ Other Expenses171.2211.3251.8259.7
Total Expenses407.9505.5602.3628.0
EBITDA220.9273.2336.9361.9
EBIT163.9202.6245.1265.9
Profit
PBT before Exceptional Items160.7194.2232.7251.4
+ Exceptional Items-2.1-1.00.00.0
Pretax Income158.7193.2232.7251.4
+ Current Tax33.241.250.755.7
+ Deferred Tax5.88.29.08.3
Tax Expense39.049.459.763.9
Net Income119.6143.8173.0187.5
+ Net Income — Continuing Ops119.6143.8173.0187.5
+ Other Comprehensive Income-0.10.00.70.9
Total Comprehensive Income119.5143.8173.6188.4
Net Income to Common118.8143.1173.0187.5
Minority Interest0.80.70.00.0
Per Share
Basic EPS11.6213.9516.8118.23
Diluted EPS11.5913.9216.7918.19
Other Comprehensive Income — detail
+ Other Comprehensive Income0.00.70.9
+ Items NOT to be Reclassified to P&L-0.10.00.91.2
+ Tax on Items NOT to be Reclassified0.00.20.3
+ Tax on Items NOT to be Reclassified — alt tag-0.0
Comprehensive Income — Owners of Parent118.70.0173.6135.3
Comprehensive Income — Non-controlling Interests0.8-0.00.00.0
Per Share — as-filed variants
Basic EPS — Continuing Operations11.6213.9516.8118.23
Diluted EPS — Continuing Operations11.5913.9216.7918.19
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit482.4596.6719.5758.3
Gross Margin %88.0587.5688.3788.47
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)160.7194.2232.7251.4
− Exceptional Items (reconciliation)-2.1-1.00.00.0
Net Income Adj (tax-effected)121.2144.6173.0187.5
EPS Adj11.7714.0216.8118.23
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001.00
Paid Up Equity Capital10.210.310.310.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.